rituximab,epcoritamab,lenalidomide
abbvie,genmab
['epcoritamab', 'lymsm']
#ash22 #lymsm #fl sc epcoritamab +lenr in 1l fl
epco 2y r 6mo len 12mo
n=41 fu 8.1 mo short 27% g3/4 neutropenia
orr 94% cr 86%
dor pfs os not mature br is my go-to. hardly use r2, so epcor2 will need randomized study to change soc imo. 
Clinician-researcher-educator bookworm @RoswellPark. Passionate about #Lymphoma #CLL #GeriOnc #PRO #MedEd Proud alum @OfficialJipmer @AIIMS_ND @UpstateNews